Details of the Drug | DrugMAP

General Information of Drug (ID: DMWZO21)

Drug Name

FP-187

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Approved	[1]
Secondary progressive multiple sclerosis	N.A.	Approved	[1]
Autoimmune diabetes	5A10	Phase 2	[2]
------------------------------------------------------------------------------------

Cross-matching ID

PubChem CID: 637568
TTD ID: D00ICY

Combinatorial Drugs (CBD)

Click to Jump to the Detailed CBD Information of This Drug

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2	ClinicalTrials.gov (NCT01230138) Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis. U.S. National Institutes of Health.